Durable Molecular Remission in a Lymphoid BP-CML Patient Harboring T315I Mutation Treated with Anti-CD19 CAR-T Therapy

Overview of attention for article published in OncoTargets and therapy, December 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 17 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

METHODS TO OVERCOME DRUG RESISTANCE BY RE-SENSITIZING CANCER CELLS TO TREATMENT WITH A…

Application WO-2023220655-A1

World Intellectual Property Organisation (WIPO)